Taken together, our experiments demonstrate that constructing a disease-specific GRN based on primary AML cell data is highly predictive for identifying highly connected network nodes required for the growth of FLT3-ITD+ AML cells. The gene discussed is FLT3; the disease is acute myeloid leukemia.